Moneycontrol PRO
you are here: HomeNewsAartidrugs
brokerage reports
Jump to
15 Results Found
  • Buy Aarti Drugs; target of Rs 844: Anand Rathi Aug 04, 2021 04:37 PM IST

    Buy Aarti Drugs; target of Rs 844: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 844 in its research report dated July 28, 2021.

  • Buy Aarti Drugs; target of Rs 848: Anand Rathi Feb 01, 2021 06:12 PM IST

    Buy Aarti Drugs; target of Rs 848: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 848 in its research report dated January 27, 2021.

  • Buy Aarti Drugs; target of Rs 813: Anand Rathi Nov 04, 2020 08:54 PM IST

    Buy Aarti Drugs; target of Rs 813: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 813 in its research report dated October 28, 2020.

  • Buy Aarti Drugs; target of Rs 2090: Anand Rathi Jul 30, 2020 06:43 PM IST

    Buy Aarti Drugs; target of Rs 2090: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 2090 in its research report dated July 28, 2020.

  • Buy Aarti Drugs; target of Rs 1028: Anand Rathi May 20, 2020 04:21 PM IST

    Buy Aarti Drugs; target of Rs 1028: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 1028 in its research report dated May 19, 2020.

  • Buy Aarti Drugs; target of Rs 745: Anand Rathi Nov 23, 2018 11:45 AM IST

    Buy Aarti Drugs; target of Rs 745: Anand Rathi

    Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 745 in its research report dated November 21, 2018.

  • Buy Aarti Drugs; target of Rs 910: Centrum Oct 04, 2018 05:01 PM IST

    Buy Aarti Drugs; target of Rs 910: Centrum

    Centrum is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 910 in its research report dated October 04, 2018.

  • Buy Aarti Drugs; target of Rs 960: Centrum May 23, 2018 03:44 PM IST

    Buy Aarti Drugs; target of Rs 960: Centrum

    Centrum is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 960 in its research report dated May 17, 2018.

  • Buy Aarti Drugs; target of Rs 940: Centrum Research Jan 15, 2018 05:51 PM IST

    Buy Aarti Drugs; target of Rs 940: Centrum Research

    Centrum Research is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 940 in its research report dated January 15, 2018.

  • Buy Aarti Drugs; target of Rs 705: Motilal Oswal Feb 10, 2016 03:33 PM IST

    Buy Aarti Drugs; target of Rs 705: Motilal Oswal

    Motilal Oswal is bullish on Suprajit Eng has recommended buy rating on the stock with a target price of Rs 705 in its research report dated Februrary 10, 2016.

  • Buy Aarti Drugs; target of Rs 790: Firstcall Aug 05, 2015 11:50 AM IST

    Buy Aarti Drugs; target of Rs 790: Firstcall

    Brokerage house Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target price of Rs 790 in its research report dated August 3, 2015.

  • Buy Aarti Drugs; target of Rs 240: Firstcall Research Jan 10, 2014 04:14 PM IST

    Buy Aarti Drugs; target of Rs 240: Firstcall Research

    Brokerage house Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target price of Rs 240 in its January 06, 2014 research report.

  • Buy Aarti Drugs; target Rs 260: Sunidhi Securities Jun 26, 2013 04:00 PM IST

    Buy Aarti Drugs; target Rs 260: Sunidhi Securities

    Sunidhi Securities is bullish on Aarti Drugs (ADL) and has recommended buy rating on the stock with a price target of Rs 260 in its June 26, 2013 research report.

  • Buy Aarti Drugs; target of Rs 210: Sunidhi Securities Apr 10, 2013 12:49 PM IST

    Buy Aarti Drugs; target of Rs 210: Sunidhi Securities

    Sunidhi Securities is bullish on Aarti Drugs and has recommended buy rating on the stock with a target of Rs 210 in its April 09, 2013 research report.

  • Buy Aarti Drugs; target of Rs 175: Firstcall Research Apr 08, 2013 12:11 PM IST

    Buy Aarti Drugs; target of Rs 175: Firstcall Research

    Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target of Rs 175 in its April 4, 2013 research report.

Sections
ISO 27001 - BSI Assurance Mark